- Home
- ZYXI vs CRBU Comparison
ZYXI vs CRBU Comparison
Compare ZYXI & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYXI
- CRBU
- Stock Information
- Founded
- ZYXI 1996
- CRBU 2011
- Country
- ZYXI United States
- CRBU United States
- Employees
- ZYXI N/A
- CRBU N/A
- Industry
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CRBU Medicinal Chemicals and Botanical Products
- Sector
- ZYXI Health Care
- CRBU Health Care
- Exchange
- ZYXI Nasdaq
- CRBU Nasdaq
- Market Cap
- ZYXI 257.1M
- CRBU 236.3M
- IPO Year
- ZYXI N/A
- CRBU 2021
- Fundamental
- Price
- ZYXI $8.95
- CRBU $2.78
- Analyst Decision
- ZYXI Strong Buy
- CRBU Strong Buy
- Analyst Count
- ZYXI 2
- CRBU 4
- Target Price
- ZYXI $14.00
- CRBU $14.00
- AVG Volume (30 Days)
- ZYXI 120.1K
- CRBU 1.4M
- Earning Date
- ZYXI 10-24-2024
- CRBU 11-06-2024
- Dividend Yield
- ZYXI N/A
- CRBU N/A
- EPS Growth
- ZYXI N/A
- CRBU N/A
- EPS
- ZYXI 0.15
- CRBU N/A
- Revenue
- ZYXI $193,665,000.00
- CRBU $11,475,000.00
- Revenue This Year
- ZYXI $10.70
- CRBU N/A
- Revenue Next Year
- ZYXI $19.78
- CRBU $3.24
- P/E Ratio
- ZYXI $60.06
- CRBU N/A
- Revenue Growth
- ZYXI 4.21
- CRBU N/A
- 52 Week Low
- ZYXI $7.15
- CRBU $1.50
- 52 Week High
- ZYXI $13.77
- CRBU $8.33
- Technical
- Relative Strength Index (RSI)
- ZYXI 54.55
- CRBU 78.45
- Support Level
- ZYXI $7.97
- CRBU $1.87
- Resistance Level
- ZYXI $9.30
- CRBU $2.12
- Average True Range (ATR)
- ZYXI 0.39
- CRBU 0.22
- MACD
- ZYXI 0.01
- CRBU 0.10
- Stochastic Oscillator
- ZYXI 55.17
- CRBU 82.15
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.